Annual SG&A
$47.28 M
+$28.83 M+156.20%
31 December 2023
Summary:
ARS Pharmaceuticals annual selling, general & administrative expenses is currently $47.28 million, with the most recent change of +$28.83 million (+156.20%) on 31 December 2023. During the last 3 years, it has risen by +$42.60 million (+908.83%). SPRY annual SG&A is now at all-time high.SPRY Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$19.28 M
+$10.34 M+115.57%
30 September 2024
Summary:
ARS Pharmaceuticals quarterly selling, general & administrative expenses is currently $19.28 million, with the most recent change of +$10.34 million (+115.57%) on 30 September 2024. Over the past year, it has increased by +$12.46 million (+182.63%). SPRY quarterly SG&A is now at all-time high.SPRY Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$600.25 M
-$49.10 M-8.91%
30 September 2024
Summary:
ARS Pharmaceuticals TTM selling, general & administrative expenses is currently -$600.25 million, with the most recent change of -$49.10 million (-8.91%) on 30 September 2024. Over the past year, it has dropped by -$647.53 million (-1369.45%). SPRY TTM SG&A is now -1320.50% below its all-time high of $51.20 million, reached on 30 September 2023.SPRY TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SPRY Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +182.6% | -1369.5% |
| 3 y3 years | +908.8% | - | - |
| 5 y5 years | - | - | - |
SPRY Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +908.8% | at high | +724.3% | -1320.5% | at low |
| 5 y | 5 years | at high | +1016.8% | at high | +724.3% | -1320.5% | at low |
| alltime | all time | at high | +1016.8% | at high | +724.3% | -1320.5% | at low |
ARS Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $19.28 M(+115.6%) | $43.01 M(+11.1%) |
| June 2024 | - | $8.94 M(+12.4%) | $38.70 M(-10.1%) |
| Mar 2024 | - | $7.96 M(+16.7%) | $43.06 M(-8.9%) |
| Dec 2023 | $47.28 M | $6.82 M(-54.4%) | $47.28 M(-7.6%) |
| Sept 2023 | - | $14.98 M(+12.6%) | $51.20 M(+30.8%) |
| June 2023 | - | $13.30 M(+9.2%) | $39.15 M(+38.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $12.18 M(+13.5%) | $28.30 M(+53.3%) |
| Dec 2022 | $18.46 M(+293.8%) | $10.73 M(+266.8%) | $18.46 M(+139.0%) |
| Sept 2022 | - | $2.93 M(+19.0%) | $7.72 M(+61.0%) |
| June 2022 | - | $2.46 M(+5.1%) | $4.80 M(+105.1%) |
| Mar 2022 | - | $2.34 M | $2.34 M |
| Dec 2021 | $4.69 M(+10.7%) | - | - |
| Dec 2020 | $4.23 M | - | - |
FAQ
- What is ARS Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly SG&A year-on-year change?
- What is ARS Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals TTM SG&A year-on-year change?
What is ARS Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of SPRY is $47.28 M
What is the all time high annual SG&A for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual selling, general & administrative expenses is $47.28 M
What is ARS Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of SPRY is $19.28 M
What is the all time high quarterly SG&A for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $19.28 M
What is ARS Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, SPRY quarterly selling, general & administrative expenses has changed by +$12.46 M (+182.63%)
What is ARS Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of SPRY is -$600.25 M
What is the all time high TTM SG&A for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high TTM selling, general & administrative expenses is $51.20 M
What is ARS Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, SPRY TTM selling, general & administrative expenses has changed by -$647.53 M (-1369.45%)